In The News
03.11.2013
Renewed Harvard-BASF initiative to advance functional materials
Established with leadership from Harvard’s Office of Technology Development, the new, multi-university initiative builds on the successful model pioneered by the BASF Advanced Research Initiative that was based at Harvard SEAS from October 2007 to present.
SEAS Web Site
02.25.2013
With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs
One of Harvard's newly formed startup companies, SciFluor Life Sciences, and a success story of its Biomedical Accelerator program, leads the way in flourine technology.
Xconomy
12.13.2012
INSERO HEALTH Completes Phase I Trial of Novel Therapy In Patients With Drug Resistant Epilepsy
Harvard's newly formed startup company, Insero Health, furthers development of Huperzine A -- a potential epilepsy drug candidate from the Harvard Medical School lab of Dr. Steven Schachter.
Press Release
08.09.2012
Collaboration for CureBeta between Evotec, Harvard University and Janssen Pharmaceuticals seeks nothing less than a cure for diabetes
Ultimately the agreement could lead to a total of USD 300 million per product for the university and its biotech partner.
partneringNEWS
08.09.2012
Collaborative research forges new ground
When Harvard University entered into a collaborative research agreement with Evotec in March 2011, it forged new ground with respect to academic-industry collaborations.
partneringNEWS
07.11.2012
Soligenix, Harvard University commence anthrax vaccine development
The Harvard lab of Douglas Melton has entered into a diabetes partnership with Johnson & Johnson subsidiary Janssen Pharmaceuticals, Inc. and German biotechnology company Evotec.
Mass High Tech
02.28.2012
Funding success, and finding it
Four years in, Accelerator program is spawning development of technology
Harvard Gazette
12.16.2011
Soligenix, Harvard University commence anthrax vaccine development
Soligenix entered a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.
PBR
11.21.2011
Aetna, Harvard Med School team on healthcare IT research
With the help of Harvard's Office of Technology Development, the Center for Biomedical Informatics at Harvard Medical School and health insurer Aetna of Hartford, CT, have entered into a research agreement aimed at improving the quality and affordability of health care.
Mass High Tech
10.25.2011
SiOnyx claims performance gains with Black Silicon solar tech
SiOnyx, a promising startup company developed through Harvard's Office of Technology Development, releases results that demonstrate higher efficiencies in comparison with solar cells already in the market.
Mass High Tech
10.09.2011
Qstream brings Q&A learning to mobile phones
Qstream’s patented “spaced education methodology”, licensed through Harvard's Office of Technology Develpment, is based on research developed at Harvard by company adviser Dr. B. Price Kerfoot, associate professor of surgery at Harvard Medical School.
BostonHerald.com
09.27.2011
Far From Any Lab, Paper Bits Find Illness
Diagnostics for All, a Harvard non-profit spinout formed with the assistance of OTD, has designed a liver damage test that fits on a postage stamp and could cost less than a penny.
New York Times
08.23.2011
Using fast DNA sequencing for medical tests
Pathogenica, Inc., a Harvard spinout from 2009, announced that one of its founders, Yemi Adesokan, has been recognized by Technology Review magazine as a TR35 Honoree for 2011.
Technology Review
8.15.2011
Harvard Money, Minds Seed Promising Start-ups
Harvard University’s Office of Technology Development has what it calls an “Accelerator Fund” that has been chugging along for four years now, and it has achieved some notable results.
Boston.com
08.11.2011
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund
Harvard University’s Office of Technology Development has what it calls an “Accelerator Fund” that has been chugging along for four years now, and it has achieved some notable results.
Xconomy.com
06.15.2011
Biobanking firm CryoXtract adds $3M from Allied Minds
Boston capital investment firm Allied Minds Inc. has led a $3 million funding of CryoXtract Instruments LLC.
Mass High Tech
06.02.2011
Small (molecule) thinking in academia
SciBX
03.16.2011
Harvard spinout named on the “The 10 Most Innovative Companies in Web” List
Fast Company Names Crimson Hexagon Number Seven on “The 10 Most Innovative Companies in Web” List
Yahoo Finance
02.28.2011
UCB in research pact with Harvard University
UCB will offer $6m to fund specific research projects led by Harvard scientists.
PBR Contract Research News
02.03.2011
UCB teams up with Harvard for CNS research
UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies
InPharm
02.03.2011
Guiding discoveries to the public
Harvard Office of Technology Development smoothes the process
Harvard Gazette - HarvardScience
02.03.2011
Innovate, create
Innovation, creativity power fresh thinking at Harvard
Harvard Gazette - HarvardScience
08.24.2010
Roche Backs New Method for Drug Delivery to Cells
The Swiss pharmaceutical giant Roche is throwing its weight behind an experimental technology that could be used to treat a number of diseases.
New York Times
06.03.2010
GnuBio launches as open-source genome sequencing startup
GnuBio is a new Harvard University spinout that is poised to become an "eBay of Biomarkers."
Mass High Tech: The Journal of New England Technology
2.04.2010
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discovery
Roche is teaming up with the Massachusetts General Hospital and Harvard University to develop new stem cell-based cell lines as disease models for early drug candidate testing.
Genetic Engineering & Biotechnology News
01.05.2010
Accelerator Fund boon to research
Harvard program provides bridge for promising life-sciences developments
Harvard Gazette - HarvardScience
11.09.2009
Harvard Among Six Schools Urging Drug Access for Poor
Harvard University and Yale University are among six schools pledging to encourage companies to give poor countries better access to drugs and medical products stemming from discoveries made on their campuses.
Bloomberg.com
05.29.2009
Harvard Awards $1M in Medical Research Grants
Harvard's Office of Technology Development via its Accelerator Fund has awarded more than $1 million in grants to help university researchers with translational work.
Mass High Tech: The Journal of New England Technology
04.24.2009
Nanosys Signs Agreements with Harvard to Combine Nanowire Technology IP
Nanosys, Inc. said it has signed two agreements with Harvard University to combine intellectual property assets to facilitate out-licensing in two areas: nanowire-based biosensors and nanowire-based non-volatile memories.
Silicon Valley Business Journal
01.16.2009
SiEnergy Systems Achieves Solid Oxide Fuel Cell Breakthrough
SiEnergy Systems, LLC has developed a breakthrough solid oxide fuel cell (SOFC) by placing a micro fuel cell directly on a silicon chip, an advance that will revolutionize the way people use power.
United Business Media
10.23.2008
Event to Showcase Harvard's Life Sciences Spin-Out Opportunities
"Unleashing Harvard Innovations: A First Look at Promising Life Sciences Spin-out Opportunities" will be presented by the Harvard Business School Health Industry Alumni Association (HBS Health) in collaboration with the Harvard University Office of Technology Development (OTD) on November 8, 2008 from 1:30-3:30PM at the Joseph B. Martin Conference Center at Harvard Medical School, Boston.
PharmaLive News
10.11.2008
Intuition + Money: An Aha Moment
It started with a Harvard physicist acting on a hunch. It ended up producing a new material, called black silicon, that could have a broad impact on technologies ranging from ultrasensitive sensors to photovoltaic cells.
The New York Times
07.25.2008
Harvard Stem Cell Research Gets Boost
British drug giant GlaxoSmithKline has agreed to sponsor at least $25 million in work at the Harvard Stem Cell Institute in Cambridge, one of the largest investments in stem cell research ever by a major pharmaceuticals company.
Boston.com
04.28.2008
OTD Participates in HBS 12th Annual Business Plan Contest
Harvard Business School (HBS) held the final round of its 12th annual Business Plan Contest yesterday in the School's Burden Auditorium, the culmination of a process that began last January with a total of some 70 student teams.
Harvard Business School
02.08.2008
Ivy Growth
Harvard University has racked up some recent wins in its effort to develop more of its life sciences research into medical products that benefit the public.
Mass High Tech: The Journal of New England Technology
01.01.2008
Retooling Tech Transfer
When physicist Eric Mazur’s research group created a new material called black silicon one day in 1998, he knew right away they were on to something.
Harvard Magazine
10.19.2007
Harvard Licensing Deal Reflects Its 'Public Mission'
Harvard University, one of the originators of a statement of how institutions can serve the public good while commercializing technology, has taken the message to heart.
The Chronicle of Higher Education
03.23.2007
Isaac Kohlberg: Harvard’s Agent of Change
Harvard University hired Isaac Kohlberg to create change at a 371-year-old institution and take its research beyond the ivory tower.
Boston Business Journal
03.07.2007
Guidelines Offered For Responsible Technology Licensing
The nation's top research universities, including Harvard University, and the Association of American Medical Colleges (AAMC) today issued a set of shared guidelines intended to protect the public interest when universities grant licenses for the rights to their latest scientific advances to private parties.
Stanford News Service
11.13.2006
A New Deal On Lifesaving Drugs
Rethinking how Harvard’s discoveries reach the world's poorest. First up: a new TB vaccine
The Crimson
11.09.2005
Harvard woos firms to fund research
"I want people to say five years from now, even three years from now, that Harvard has the most effective technology-transfer program in the country," said Isaac Kohlberg, Harvard's new chief of technology development.
Boston.com
11.11.2004
Kohlberg is named chief technology development officer
New position was created in recognition of the changing nature of science Harvard University Gazette
Harvard Gazette